Issue Special Issue 2/2003
1st Workshop of the International Society for Behçet's Disease (ISBD) on Pathophysiology and Treatment of Behçet's Disease
Content (13 Articles)
Meeting abstract
Perspectives of the Working Group on Drug Trials including Collaborative Trials of the ISBD and rationale for new clinical trials
S Assaad-Khalil
Meeting abstract
Cytotoxic drugs in ocular lesions of Behçet's disease
F Davatchi, F Shahram, H Chams, A Nadji, AR Jamshidi, C Chams, M Akbarian, F Gharibdoost, M Sedigh, B Sadeghi
Meeting abstract
The use of interferon-alfa in Behçet's disease: review of the literature
I Kötter, I Günaydin, M Zierhut, N Stübiger
Meeting abstract
Efficacy of recombinant human interferon-alfa2a on ocular and extra-ocular manifestations of Behçet's disease and influence on cells of the immune system: results of an open four center trial
I Kötter, M Treusch, R Vonthein, M Zierhut, A Eckstein, T Ness, I Günaydin, B Grimbacher, S Blaschke, HH Peter, N Stübiger
Meeting abstract
Migration of dendritic cells into the lymphatics: the Langerhans cell example
N Romani, P Stoitzner, S Ebner, H Stössel, S Holzmann, G Ratzinger, P Fritsch
Meeting abstract
Viral infection of retinal pigment epithelium: a possible role for initiation of Behçet's disease
EU Irschick, HP Huemer, C Larcher, R Sgonc, W Göttinger
Meeting abstract
Regulation of inflammatory CD28- T-helper cells by HLA class I molecules: a new cellular model for Behçet's disease?
C Duftner, C Goldberger, E Märker-Hermann, M Schirmer
Meeting abstract
Immunosuppressive effects of gemcitabine in the HSV-induced Behçet's disease like mouse model
S Sohn, M Lutz, HJ Kwon, G Konwalinka, S Lee, M Schirmer
Meeting abstract
Streptococcal antigen in the pathogenesis of Behçet's disease
F Kaneko, H Yanagihori, M Tojo, E Isogai, SN Lin, K Oguma